[PDF][PDF] Molecular mechanisms of melatonin-induced alleviation of synaptic dysfunction and neuroinflammation in Parkinson's disease: a review.

YL Guo, XJ Wei, T Zhang, T Sun - European Review for …, 2023 - europeanreview.org
Molecular mechanisms of melatonin-induced alleviation of synaptic dysfunction and
neuroinflammation in Parkinson’s disease: a Page 1 5070 Abstract. – This review focuses on …

Transcranial direct current stimulation for Parkinson's disease: Systematic review and meta-analysis of motor and cognitive effects

Z Duan, C Zhang - npj Parkinson's Disease, 2024 - nature.com
Transcranial direct current stimulation (tDCS) is a promising noninvasive intervention for
Parkinson's disease (PD). However, studies of its motor and cognitive effect have produced …

Advances in graphene-based nanoplatforms and their application in Parkinson's disease

T Oz, AK Kaushik, M Kujawska - Materials Advances, 2023 - pubs.rsc.org
Parkinson's disease (PD) is a progressive, complex, and chronic neurodegenerative
disorder that remains challenging to cure and diagnose in the early stage. The …

[HTML][HTML] Translating ultrasound-mediated drug delivery technologies for CNS applications

E Perolina, S Meissner, B Raos, B Harland… - Advanced Drug Delivery …, 2024 - Elsevier
Ultrasound enhances drug delivery into the central nervous system (CNS) by opening
barriers between the blood and CNS and by triggering release of drugs from carriers. A key …

[HTML][HTML] The Neuroprotective Effects of Electroacupuncture on Parkinson's Disease and the Underlying Molecular Mechanisms

Q Han, P Chen, X Chen, L Wang, R Huang… - Journal of Integrative …, 2024 - imrpress.com
Parkinson's disease (PD) is a chronic neurodegenerative disease whose main pathological
features are the degeneration of dopamine neurons and deposition of α-synuclein in …

[HTML][HTML] Gene Therapy for Parkinson's Disease Using Midbrain Developmental Genes to Regulate Dopaminergic Neuronal Maintenance

J Kim, MY Chang - International Journal of Molecular Sciences, 2024 - mdpi.com
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder. It is
characterized by the progressive loss of dopaminergic (DAnergic) neurons in the substantia …

[HTML][HTML] Rhythmic auditory stimulation for motor rehabilitation in Parkinson's disease

V Pando-Naude, KV Jespersen… - … Cochrane Database of …, 2024 - ncbi.nlm.nih.gov
Rhythmic auditory stimulation for motor rehabilitation in Parkinson’s disease - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

[HTML][HTML] Novel perspective of therapeutic modules to overcome motor and nonmotor symptoms in Parkinson's disease

A Kumar, AK Gupta, PK Singh - AIMS neuroscience, 2024 - pmc.ncbi.nlm.nih.gov
Parkinson's disease (PD) is a neurodegenerative disorder that involves the loss of
dopaminergic neurons, which leads to motor and non-motor symptoms that have a …

Neuroimaging and serum biomarkers of neurodegeneration and neuroplasticity in Parkinson's disease patients treated by intermittent theta-burst stimulation over the …

R Rashid-López, P Macías-García… - Frontiers in Aging …, 2023 - frontiersin.org
Background and objectives Intermittent theta-burst stimulation (iTBS) is a patterned form of
excitatory transcranial magnetic stimulation that has yielded encouraging results as an …

[HTML][HTML] Oligodendrocytes, the Forgotten Target of Gene Therapy

Y Ozgür-Gunes, C Le Stunff, P Bougnères - Cells, 2024 - mdpi.com
If the billions of oligodendrocytes (OLs) populating the central nervous system (CNS) of
patients could express their feelings, they would undoubtedly tell gene therapists about their …